Bernie Sanders bashes Novo again: "They are exploiting our broken healthcare system"

Novo CEO Lars Fruergaard Jørgensen does not believe that criticism of Novo Nordisk’s prices is justified, because the American healthcare system is characterized by large discounts. 
Photo: Andrew Harnik
Photo: Andrew Harnik

Novo Nordisk is exploiting the American healthcare system to charge absurdly high prices for drugs like Ozempic and Wegovy, says Bernie Sanders, Chairman of the Senate Health Committee, in an interview with Danish daily Politiken.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Foto: Mike Blake/Reuters/Ritzau Scanpix

    Gilead Sciences CMO to leave early 2025

    For subscribers

    Further reading